BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//pretalx//cfp.cccv.de//39c3//talk//SMWCFE
BEGIN:VTIMEZONE
TZID:CET
BEGIN:STANDARD
DTSTART:20001029T040000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10
TZNAME:CET
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20000326T030000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3
TZNAME:CEST
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:pretalx-39c3-SMWCFE@cfp.cccv.de
DTSTART;TZID=CET:20251227T135000
DTEND;TZID=CET:20251227T143000
DESCRIPTION:Did you ever wonder where all the drugs\, which you can get at 
 a pharmacy\, come from? Who makes them\, and how? Well\, there is no easy 
 answer\, because the process of drug discovery and development is a very c
 omplex\, expensive\, and challenging journey\, riddled with many risks and
  failures. This holds true for all types of drugs\, from a simple pill to 
 an mRNA vaccine or a gene therapy. Today\, scientists support this process
  with a variety of AI applications\, cutting-edge technologies\, automatio
 n\, and a huge amount of data. But can the race for new medicines and cure
 s succeed only through more technology\, or do we need to rethink the enti
 re process? Let’s take a look at how the drug discovery and development 
 process has worked so far\, and how this entire process is changing – fo
 r better or worse.
DTSTAMP:20260904T194833Z
LOCATION:Zero
SUMMARY:Developing New Medicines in the Age of AI and Personalized Medicine
  - Dennis Özcelik
URL:https://cfp.cccv.de/39c3/talk/SMWCFE/
END:VEVENT
END:VCALENDAR